Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

DNA Methylation Market Snapshot (2023 to 2033)

The global DNA methylation market is expected to garner a market value of US$ 1437.5 Million in 2023 and is expected to accumulate a market value of US$ 5815.49 Million by registering a CAGR of 15% in the forecast period 2023 to 2033. Growth of the DNA methylation market can be attributed to increasing cases of cancer globally remains the primary driver of its anticipated growth. The market for DNA methylation registered a CAGR of 11% in the historical period 2016 to 2021.

Furthermore, the declining cost of treatment with streamlining of product approvals also remains a steady driver of growth. Significant government support for research and development activities with direct funding continues to open new opportunities for growth.

Report Attribute Details
Expected Market Value (2023) US$ 1437.5 Million
Anticipated Forecast Value (2033) US$ 5815.49 Million
Projected Growth Rate (2023 to 2033) 15% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 DNA Methylation Market Demand Analysis vs. Forecast 2023 to 2033

According to market research and competitive intelligence provider Future Market Insights- the market for DNA methylation reflected a value of 9% during the historical period, 2017 to 2021.

DNA methylation remains a promising technique to advance research in core areas of chronic disease treatment. In September 2022, researchers from the University of California published a journal in Nature Communications stating the potential application of cell-free DNA methylation as a promising biomarker for cancer detection at an early stage.

Thus, the market for DNA methylation is expected to register a CAGR of 16.30% in the forecast period 2023 to 2033.

Which are Some Prominent Drivers of DNA Methylation Market?

Accessibility to test kits increasing the use of DNA methylation

The COVID-19 outbreak impacted the market negatively due to movement restrictions, which hindered research and testing at research centers and laboratories. However, the post-pandemic, reopening of research institutions resulted in increased usage of DNA methylation. Moreover, the accessibility of a broad range of test kits has further created significant opportunities for market players.

The DNA methylation analysis technique helps scientists gain valuable insights into gene regulation and potential biomarker identification. Abnormal DNA methylation has been associated with several disease processes, such as obesity, cancer, and others. It also promises potential application in agronomic research to study responses to temperature extremes, drought, and other environmental changes. In June 2022, a research article published in MDPI stated that DNA methylation is mostly studied in epigenetic marks in plants and others. It is considered a sustainable source of variation contributing to crop production and health.

Advanced technology and next-generation technology favoring the growth of the DNA methylation market

Furthermore, various high-throughput technologies such as microarrays and next-generation sequencing (NGS) have facilitated studies related to genome-wide methylation profiling. These technologies offer ways to understand DNA methylation significance, providing insights into the functional effects of variation. For instance, in February 2021, Twist Bioscience launched the NGS Methylation Detection System, which is to be used for the analysis of liquid biopsy cancer and epigenetic studies. This would further provide insight into disease pathology.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the DNA Methylation Market?

Lack of expertise and unskilled professionals creating obstacles to market growth

A lack of expertise to perform DNA methylation experiments could restrict the growth. DNA methylation holds significant potential in various biotechnology applications, while the relatively low number of skilled professionals remains an obstacle to growth. All these factors may restrict the growth of the DNA methylation market in the forecast period 2023 to 2033.

Regional Insights

Large Network of Manufacturing and Research and Development Facilities Spurring Growth of DNA Methylation in North America?

Investments in research accelerating DNA methylation market growth

North America is expected to account for the largest market share in 2023. This can be attributed to the large network of manufacturing and Research and Development facilities, and the increase in product launches and approvals. Moreover, the growing demand for protein expression systems has also contributed significantly to regional growth.

In May 2022, Twist Bioscience introduced a human methylome panel to allow methylation fractions to be detected in a wide range of applications. This supports the identification of epigenetic targets and the discovery of differentially methylated areas for human development and cancer metastasis research. North America’s contribution through research and development is creating lucrative opportunities for DNA methylation. Thus, North America is expected to possess a 40% market share in the DNA methylation market in 2023.

Government Initiatives Bolstering Growth of DNA Methylation in the Asia Pacific?

Global players penetrating the Asia Pacific market region for wider reach

Asia Pacific is estimated to be the fastest-growing segment over the forecast period due to growing support from the government with several initiatives. Furthermore, the growing focus of global players on emerging markets of Asia Pacific also remains a promising driver of growth.

In September 2020, AnchorDxentered announced the development of a liquid biopsy diagnostic model for breast cancer detection at an early stage. This diagnostic model is focused on circulating cell-free DNA-based methylation patterns. Similarly, in August 2022, Oncgnostics GmbH received authorization from the Chinese government to market its GynTect test to doctors and patients. This is the first methylation test to be authorized in China for the triage of cervical cancer cases. Thus, Asia Pacific is expected to possess a 38% market share in the DNA methylation market in 2023.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-Wise Insights

Rapid Advancements in Technology Favoring Growth of Sequencing in DNA Methylation?

Cost-effective and accurate results favoring the use of sequencing for DNA methylation

The sequencing segment captured the highest market share in 2021 due to the rapid advancement in technologies that offer cost-effective, accurate, and quick results. Bisulfite genomic sequencing is considered a gold-standard technology. Researchers have employed whole-genome bisulfite sequencing to understand the epigenetic landscape of immune-related disorders caused by tobacco use.

Growth of this technology in research studies to understand the adverse effects of smoking and how it relates to diseases promises further growth opportunities in the segment. Thus, sequencing is expected to possess a 35% market share in the DNA methylation market in 2023.

Demand for analyzing DNA making PCR essential for screening in DNA methylation

PCR is anticipated to witness significant growth in the coming years owing to an increase in its use in diagnostics and DNA sequencing procedures. During Covid-19, the demand for PCR technology significantly increased in relevance as a diagnostic procedure. PCR-based methods are primarily used to analyze DNA methylation on a gene-by-gene basis.

In May 2022, Pentabase A/S announced the launch of a qPCR-based assay, EpiDirect, for detecting DNA methylation without pre-treatment. This product aims to create a cancer screening technique that can detect cancers in a cell-free DNA environment.

Quick Turnaround Times Accelerating Growth of Consumables for DNA Methylation Market?

Wide application in end-user industries making consumables a viable option

The consumables segment is expected to dominate the DNA methylation market in 2023, as it is majorly used in the DNA sequencing procedures and diagnosis process. Growing demand for quick turnaround times and high throughput results are also strong contributors to the growth. A wide range of consumables is used in the research industry, which includes tubes, vials, microarray panels, dispensers, and pipette tips.

High volume requirements of these consumables continue to boost the overall demand in the market. In April 2022, PacBio announced of expansion of its product offering by adding new DNA methylation consumables. These are made directly available to all its customers using Sequel II and Sequel IIe systems. Thus, consumables are expected to possess a 35% market share in the DNA methylation market in 2023.

Protein-modifying enzymes experiencing lucrative growth for DNA methylation

The enzyme segment is anticipated to witness lucrative growth in the coming years due to the increasing demand for protein-modifying enzymes in the DNA methylation technique. These are widely used in agrigenomic research, genomic research, and genome-wide analysis. The usage of enzymes in DNA methylation reactions during sequencing analysis, such as Illumina sequencing and pyrosequencing remains prominent. Moreover, the utilization of next-generation sequencing technology has bolstered the demand for enzymes in the biotechnology industry.

Growth of Clinical Trials Accelerating Growth of Trials of DNA Methylation?

Demand for potential biomarkers increasing growth of clinical trials

The clinical research segment is expected to capture the highest market share in 2023, thanks to the increasing number of clinical trials for several diseases globally. Furthermore, increased Research and Development expenditure, and increasing demand for potential biomarkers promise more growth opportunities.

In July 2020, an article published in Springer stated that disease-linked methylation changes could be used as biomarkers at all clinical disease management stages. These various stages include predisposition and risk assessment screening through early diagnostics to the personalized patient care of chronic and relapse disease. Therefore, disease-related discovery is a promising biomarker and a potential game-changer for precision medicine. Thus, clinical research is expected to possess a 40% market share of the DNA methylation market in 2023.

Accuracy of pathological diagnosis increasing dependency on diagnostic systems

The diagnostic segment is anticipated to witness the fastest growth in the coming years with a CAGR of 16%. DNA methylation profiling is an emerging tool that promises to increase the accuracy of pathological diagnosis.

In January 2022, an article published in PubMed stated that DNA methylation patterns in circulating tumor DNA (ctDNA) offer considerable promise for the categorization and detection of cancer with the least invasive approach. Methylation profiling can be widely used as a cancer diagnostic tool for all tumor types, despite its recent arrival on the scene

Molecular Biology and Genomics Driving Growth of DNA Methylation Market?

High throughput technologies boosting the use of DNA methylation in molecular biology and genomics

The pharmaceutical and biotechnology end-use segment is expected to capture the highest market share in 2023. The increased adoption of DNA methylation in the field of molecular biology and genomics & remains the primary driver of this growth. Moreover, increasing usage of high throughput technologies such as NGS by key market players also continues to open new opportunities for growth.

In June 2020, Base Genomics announced of leveraging TET-assisted pyridine borane sequencing (TAPS) technology developed by the University of Oxford to find epigenetic signs of cancer in the blood. Thus, the pharmaceutical and biotechnology end-use segment is expected to possess a 42% market share for DNA methylation in 2023.

Research & development activities along with funding from the government contributing to research and academia segment

Research and Academia are anticipated to witness significant growth in the coming years owing to increased Research and Development in the epigenetics sector. This along with increasing government support in terms of funding remains a promising driver of growth.

In July 2022, according to a study published in Genome Biology, DNA methylation in bacteria controls reproduction, gene expression, and pathogenicity. The tissue-specific gene expression that regulates a cell's identity, such as if it’s a brain cell or a skin cell, is regulated by DNA methylation Quality research remains the backbone of growth in the market.

Start-ups for DNA Methylation Market

Key players in the DNA methylation market are Base Genomics, EpiQMAx, genknowme, Epify, and EpigenCare

  • Epigenetics company Base Genomics has received seed funding of US$ 11 Million to progress the development of its DNA methylation technology. The company is focusing on sequencing large information from simple blood tests.
  • Epify, a Dutch startup is focusing on developing epigenetic biomarkers for cancer diagnosis. The startup’s solutions detect different kinds of epigenetic modifications, including DNA methylations, histone modifications, and RNA transcript modifications.

Market Competition

Key players operating in the DNA methylation industry are taking several initiatives such as strategic collaborations, partnerships, and geographical expansion in emerging regions.

Some prominent players in the global DNA methylation market include New England Biolabs, Sysmex Corporation, Abcam plc., F. Hoffmann-La Roche Ltd., Diagenode Diagnostics S.A., Thermo-Fisher Scientific Inc., Agilent Technologies Inc., BioRad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Active Motif, Inc., Illumina Inc., EpiGentek Group Inc., Pacific Biosciences Inc., New England Biolabs Inc., Merck KGaA, Zymo Research Corporation, PerkinElmer Inc.

  • In June 2022, Boca ScientificInc. announced the expansion of its product portfolio by adding MethylDetect DNA Methylation Assay Kits. These factors continue its robust adoption at research institutes and various pharmaceutical and biotechnology companies.
  • In June 2020, Foundation Medicine, Inc acquired Lexent Bio, Inc. to expand the company’s liquid biopsy platforms to improve patient cancer care. This novel technique can be used to chronicle the progression of cancer in a diverse population of patients.

Report Scope

Report Attribute Details
Market Value in 2023 US$ 1437.5 Million
Market Value in 2033 US$ 5815.49 Million
Growth Rate CAGR of 15% from 2023 to 2033
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in USD Million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Technology
  • Product Type
  • Application
  • End Use
  • Region
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC Countries
  • South Africa
Key Companies Profiled
  • New England Biolabs
  • Sysmex Corporation
  • Abcam plc.
  • F. Hoffmann-La Roche Ltd.
  • Diagenode Diagnostics S.A.
  • Thermo-Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • BioRad Laboratories Inc.
  • Exact Sciences Corporation
  • QIAGEN N.V.
  • Active Motif, Inc.
  • Illumina Inc.
  • EpiGentek Group Inc.
  • Pacific Biosciences Inc.
  • New England Biolabs Inc.
  • Merck KGaA
  • Zymo Research Corporation
  • PerkinElmer Inc.
Customization Available Upon Request

Key Segments Profiled in the DNA Methylation Industry Survey

Technology:

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Sequencing
  • Others

Product:

  • Consumables
  • Kits & Reagents
  • Enzymes
  • Instruments & Software

Application:

  • Gene Therapy
  • Clinical Research
  • Diagnostics
  • Others

End-use:

  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academia

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

At what rate did the DNA methylation market flourish from 2017 to 2021?

From 2017 to 2021, the DNA methylation market grew at a CAGR of 11%

What will be the growth rate of the global DNA methylation market during the forecast period?

The global DNA methylation market is expected to grow with a 15% CAGR from 2023 to 2033.

What will be the projected market size of the DNA methylation market by 2033?

As of 2033, the DNA methylation market is expected to reach US$ 5815.49 Million

Which technology segment is expected to dominate the global DNA methylation market during 2023?

Sequencing is expected to possess a 35% market share in the DNA methylation market in 2023.

Which end use segment is expected to dominate the global DNA methylation market during 2023?

The pharmaceutical and biotechnology end-use segment is expected to possess a 42% market share for DNA methylation in 2023.

Which type of application is expected to dominate the global DNA methylation market during 2023?

Clinical research is expected to possess a 40% market share in the DNA methylation market in 2023.

How is the North America DNA methylation market projected to grow in 2023?

North America is expected to possess a 40% market share in the DNA methylation market in 2023.

How is the Asia Pacific DNA methylation market projected to grow in 2023?

Asia Pacific is expected to possess a 38% market share in the DNA methylation market in 2023.

Table of Content

1. Executive Summary | DNA Methylation Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2022 to 2032

        5.3.1. Polymerase Chain Reaction (PCR)

        5.3.2. Microarray

        5.3.3. Sequencing

        5.3.4. Others

    5.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Technology, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Product, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2022 to 2032

        6.3.1. Consumables

        6.3.2. Kits & Reagents

        6.3.3. Enzymes

        6.3.4. Instruments & Software

    6.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By Product, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032

        7.3.1. Gene Therapy

        7.3.2. Clinical Research

        7.3.3. Diagnostics

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021

    7.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2017 to 2021

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2022 to 2032

        8.3.1. Hospital & Diagnostic Laboratories

        8.3.2. Pharmaceutical & Biotechnology Companies

        8.3.3. Research & Academia

    8.4. Y-o-Y Growth Trend Analysis By End-use, 2017 to 2021

    8.5. Absolute $ Opportunity Analysis By End-use, 2022 to 2032

9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. South Asia

        9.3.5. East Asia

        9.3.6. Oceania

        9.3.7. Middle East and Africa(MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Technology

        10.2.3. By Product

        10.2.4. By Application

        10.2.5. By End-use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Technology

        10.3.3. By Product

        10.3.4. By Application

        10.3.5. By End-use

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Technology

        11.2.3. By Product

        11.2.4. By Application

        11.2.5. By End-use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Technology

        11.3.3. By Product

        11.3.4. By Application

        11.3.5. By End-use

    11.4. Key Takeaways

12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United Kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Technology

        12.2.3. By Product

        12.2.4. By Application

        12.2.5. By End-use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Technology

        12.3.3. By Product

        12.3.4. By Application

        12.3.5. By End-use

    12.4. Key Takeaways

13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Malaysia

            13.2.1.3. Singapore

            13.2.1.4. Thailand

            13.2.1.5. Rest of South Asia

        13.2.2. By Technology

        13.2.3. By Product

        13.2.4. By Application

        13.2.5. By End-use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Technology

        13.3.3. By Product

        13.3.4. By Application

        13.3.5. By End-use

    13.4. Key Takeaways

14. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Technology

        14.2.3. By Product

        14.2.4. By Application

        14.2.5. By End-use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Technology

        14.3.3. By Product

        14.3.4. By Application

        14.3.5. By End-use

    14.4. Key Takeaways

15. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        15.2.1. By Country

            15.2.1.1. Australia

            15.2.1.2. New Zealand

        15.2.2. By Technology

        15.2.3. By Product

        15.2.4. By Application

        15.2.5. By End-use

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Technology

        15.3.3. By Product

        15.3.4. By Application

        15.3.5. By End-use

    15.4. Key Takeaways

16. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of Middle East and Africa(MEA)

        16.2.2. By Technology

        16.2.3. By Product

        16.2.4. By Application

        16.2.5. By End-use

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Technology

        16.3.3. By Product

        16.3.4. By Application

        16.3.5. By End-use

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2021

            17.1.2.1. By Technology

            17.1.2.2. By Product

            17.1.2.3. By Application

            17.1.2.4. By End-use

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2021

            17.2.2.1. By Technology

            17.2.2.2. By Product

            17.2.2.3. By Application

            17.2.2.4. By End-use

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2021

            17.3.2.1. By Technology

            17.3.2.2. By Product

            17.3.2.3. By Application

            17.3.2.4. By End-use

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2021

            17.4.2.1. By Technology

            17.4.2.2. By Product

            17.4.2.3. By Application

            17.4.2.4. By End-use

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2021

            17.5.2.1. By Technology

            17.5.2.2. By Product

            17.5.2.3. By Application

            17.5.2.4. By End-use

    17.6. United Kingdom

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2021

            17.6.2.1. By Technology

            17.6.2.2. By Product

            17.6.2.3. By Application

            17.6.2.4. By End-use

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2021

            17.7.2.1. By Technology

            17.7.2.2. By Product

            17.7.2.3. By Application

            17.7.2.4. By End-use

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2021

            17.8.2.1. By Technology

            17.8.2.2. By Product

            17.8.2.3. By Application

            17.8.2.4. By End-use

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2021

            17.9.2.1. By Technology

            17.9.2.2. By Product

            17.9.2.3. By Application

            17.9.2.4. By End-use

    17.10. India

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2021

            17.10.2.1. By Technology

            17.10.2.2. By Product

            17.10.2.3. By Application

            17.10.2.4. By End-use

    17.11. Malaysia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2021

            17.11.2.1. By Technology

            17.11.2.2. By Product

            17.11.2.3. By Application

            17.11.2.4. By End-use

    17.12. Singapore

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2021

            17.12.2.1. By Technology

            17.12.2.2. By Product

            17.12.2.3. By Application

            17.12.2.4. By End-use

    17.13. Thailand

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2021

            17.13.2.1. By Technology

            17.13.2.2. By Product

            17.13.2.3. By Application

            17.13.2.4. By End-use

    17.14. China

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2021

            17.14.2.1. By Technology

            17.14.2.2. By Product

            17.14.2.3. By Application

            17.14.2.4. By End-use

    17.15. Japan

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2021

            17.15.2.1. By Technology

            17.15.2.2. By Product

            17.15.2.3. By Application

            17.15.2.4. By End-use

    17.16. South Korea

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2021

            17.16.2.1. By Technology

            17.16.2.2. By Product

            17.16.2.3. By Application

            17.16.2.4. By End-use

    17.17. Australia

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2021

            17.17.2.1. By Technology

            17.17.2.2. By Product

            17.17.2.3. By Application

            17.17.2.4. By End-use

    17.18. New Zealand

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2021

            17.18.2.1. By Technology

            17.18.2.2. By Product

            17.18.2.3. By Application

            17.18.2.4. By End-use

    17.19. GCC Countries

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2021

            17.19.2.1. By Technology

            17.19.2.2. By Product

            17.19.2.3. By Application

            17.19.2.4. By End-use

    17.20. South Africa

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2021

            17.20.2.1. By Technology

            17.20.2.2. By Product

            17.20.2.3. By Application

            17.20.2.4. By End-use

    17.21. Israel

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2021

            17.21.2.1. By Technology

            17.21.2.2. By Product

            17.21.2.3. By Application

            17.21.2.4. By End-use

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Technology

        18.3.3. By Product

        18.3.4. By Application

        18.3.5. By End-use

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. New England Biolabs

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Sysmex Corporation

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Abcam plc.

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. F. Hoffmann-La Roche Ltd.

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Diagenode Diagnostics S.A.

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Thermo-Fisher Scientific Inc.

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Agilent Technologies Inc.

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. BioRad Laboratories Inc.

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Exact Sciences Corporation

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. QIAGEN N.V.

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

        19.1.11. Active Motif, Inc.

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

        19.1.12. Illumina Inc.

            19.1.12.1. Overview

            19.1.12.2. Product Portfolio

            19.1.12.3. Profitability by Market Segments

            19.1.12.4. Sales Footprint

            19.1.12.5. Strategy Overview

                19.1.12.5.1. Marketing Strategy

        19.1.13. EpiGentek Group Inc.

            19.1.13.1. Overview

            19.1.13.2. Product Portfolio

            19.1.13.3. Profitability by Market Segments

            19.1.13.4. Sales Footprint

            19.1.13.5. Strategy Overview

                19.1.13.5.1. Marketing Strategy

        19.1.14. Pacific Biosciences Inc.

            19.1.14.1. Overview

            19.1.14.2. Product Portfolio

            19.1.14.3. Profitability by Market Segments

            19.1.14.4. Sales Footprint

            19.1.14.5. Strategy Overview

                19.1.14.5.1. Marketing Strategy

        19.1.15. New England Biolabs Inc.

            19.1.15.1. Overview

            19.1.15.2. Product Portfolio

            19.1.15.3. Profitability by Market Segments

            19.1.15.4. Sales Footprint

            19.1.15.5. Strategy Overview

                19.1.15.5.1. Marketing Strategy

        19.1.16. Merck KGaA

            19.1.16.1. Overview

            19.1.16.2. Product Portfolio

            19.1.16.3. Profitability by Market Segments

            19.1.16.4. Sales Footprint

            19.1.16.5. Strategy Overview

                19.1.16.5.1. Marketing Strategy

        19.1.17. Zymo Research Corporation

            19.1.17.1. Overview

            19.1.17.2. Product Portfolio

            19.1.17.3. Profitability by Market Segments

            19.1.17.4. Sales Footprint

            19.1.17.5. Strategy Overview

                19.1.17.5.1. Marketing Strategy

        19.1.18. PerkinElmer Inc.

            19.1.18.1. Overview

            19.1.18.2. Product Portfolio

            19.1.18.3. Profitability by Market Segments

            19.1.18.4. Sales Footprint

            19.1.18.5. Strategy Overview

                19.1.18.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

DNA Synthesis Market

Published : August 2023

Healthcare

DNA Sequencing Services Market

Published : August 2023

Healthcare

DNA/RNA Extraction Market

Published : June 2023

Healthcare

DNA Polymerase Market

Published : May 2023

Explore Healthcare Insights

View Reports